PHYTOESTROGEN ANALOGUES BLOCK CA2+ INFLUX IN PLATELETS
409
trixydroxystilbene) after short-term or prolonged adminis-
tration of red wine to rats. Int J Tissue React 1996;18:
67–71.
tors from polygonum cuspidatum. J Nat Prod 1993;56:
1805–10.
25. Gouy H, Cefai D, Cristensen SB, et al. Ca2+ influx in
human T lymphocytes is induced independently of inositol
phosphate production by mobilization of intracellular Ca2+
stores: a study with the Ca2+ endoplasmic reticulum-
ATPase inhibitor thapsigargin. Eur J Immunol 1990;20:
2269–75.
5. Demrow HS, Slane PR, Folts JD. Administration of wine
and grape juice inhibits in vivo platelet activity and throm-
bosis in stenosed canine coronary arteries. Circulation
1995;91:1182–8.
6. Shoene NW, Guidry CA. Dietary soy isoflavones inhibit
activation of rat platelets. J Nutr Biochem 1999;10:421–6.
7. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a
molecule whose time has come? and gone? Clin Biochem
1997;30:91–113.
26. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a spe-
cific inhibitor of tyrosine-specific protein kinases. J Biol
Chem 1987;262:5592–5.
27. Thastrup O, Cullen PJ, Drobak BK, et al. Thapsigargin, a
8. Sage SO. Calcium entry mechanisms in human platelets.
Exp Physiol 1997;82:807–23.
tumor promoter, discharges intracellular Ca2+ stores by
specific inhibition of the endoplasmic reticulum Ca2+
-
9. Hourani SMO, Cusack NJ. Pharmacological receptors on
blood platelets. Pharmacol Rev 1991;43:243–98.
10. Vu T-KH, Hung DT, Wheaton VI, et al. Molecular cloning
of a functional thrombin receptor reveals a novel proteo-
lytic mechanism of receptor activation. Cell 1991;64:
1057–68.
11. Brass L, Hoxie J, Kieber-Emmons, et al. Agonist receptors
and G proteins as mediators of platelet activation. In: Authi
KS, Watson SP, VV Kakkar (eds). Mechanisms of Platelet
Activation and Control. New York: Plenum Press,
1993:17–36.
ATPase. Proc Natl Acad Sci U S A 1990;87:2466–70.
28. Vostal JG, Shafer B. Thapsigargin-induced calcium influx
in the absence of detectable tyrosine phosphorylation in
human platelets. J Biol Chem 1996:271:19524–9.
29. Jakson TR, Patterson SI, Thastrup O, et al. A novel tumor
promoter, thapsigargin, transiently increases cytoplasmic
free Ca2+ without generation of inositol phosphates in NG
115–401L neuronal cells. Biochem J 1988;253:81–6.
30. Trepakova ES, Cohen RA, Bolotina VM. Nitric oxide in-
hibits capacitative cation influx in human platelets by pro-
moting sarcoplasmic/endoplasmic reticulum Ca2+-ATP-
ase-dependent refilling of Ca2+ stores. Circ Res 1999;84:
201–9.
12. Putney JW, Mckay RR. Capacitative calcium entry chan-
nels. Bioessays 1999;21:38–46.
13. Parekh AB, Penner R. Store depletion and calcium influx.
Physiol Rev 1997;77:901–30.
14. Groschnner K, Hingel S, Lintschinger B, al. Trp proteins
form storeoperated cation channels in human vascular en-
dothelial cells. FEBS Lett 1998;437:101–6.
15. Harteneck C, Plant TD, Schultz G. From worm to man:
three subfamilies of TRP channels. Trends Neurosci 2000;
23:159–66.
16. Ma HT, Patterson RL, Van Rossum DB, et al. Requirement
for the inositol triphosphate receptor for activation of
storeoperated Ca2+ channels. Science 2000;287:1647–51.
17. Rosado JA, Sage SO. Coupling between inositol 1,4,5-
triphosphate receptor and human transient receptor poten-
tial channel 1 when intracellular Ca2+ stores are depleted.
Biochem J 2000;350:631–5.
31. Brown AS, Moro MA, Masse JM, et al. Nitric oxide-
dependent and independent effects on human platelets
treated with peroxynitrite. Cardiovasc Res 1998;40:380–8.
32. Favre CJ, Ufret-Vincenty CA, Stone MR, et al. Ca2+ pool
emptying stimulates Ca2+ entry activated by S-nitro-
sylation. J Biol Chem 1998;273:30855–8.
33. Sargeant P, Farndale RW, Sage SO. The tyrosine kinase
inhibitors methyl 2,5-dihydroxycinnamate and genistein
reduce thrombin-evoked tyrosine phosphorylation and
Ca2+ entry in human platelets. FEBS Lett 1993;315:242–6.
34. Sargeant P, Farndale RW, Sage SO. The imidazole anti-
mycotics econazole and miconazole reduce agonist evoked
protein tyrosine phosphorylation and evoke membrane de-
polarization in human platelets: cautions for their use in
studying Ca2+ signaling pathways. Cell Calcium 1994;16:
413–8.
18. Rosado JA, Jenner S, Sage SO. A role for the actin cyto-
skeleton in the initiation and maintenance of store-
mediated calcium entry into human platelets. J Biol Chem
2000;275:7527–33.
35. Piskula MK, Yamakoshi J, Iwai Y. Daidzein and genistein
but not their glucosides are absorbed from the rat stomach.
FEBS Lett 1999;26:287–91.
19. Dobrydneva Y, Williams RL, Blackmore PF. Trans-
resveratrol inhibits calcium influx in thrombin-stimulated
human platelets. Br J Pharmacol 1999;128:149–57.
20. Wahala K, Hase TA. Hydrogen transfer reduction of iso-
flavones. Heterocycles 1989;28:183–6.
21. Nolan RD, Lapetina EG. Thrombin stimulates the produc-
tion of a novel polyphosphoinositide in human platelets. J
Biol Chem 1990;265:2441–5.
22. Blackmore PF, Beebe SJ, Danforth DR, et al. Progesterone
and 17alpha-hydroxyprogesterone: novel stimulators of
calcium influx in human sperm. J Biol Chem 1990;265:
1376–80.
23. Ozaki Y, Yatomi Y, Kume S. Evaluation of platelet cal-
cium ion mobilization by the use of various divalent ions.
Cell Calcium 1992;13:19–27.
36. Trovati M, Massuco P, Mattiello L, et al. Insulin increases
guanosine-3Ј,5Ј-cyclic monophosphate in human platelets:
a mechanism involved in the insulin anti-aggregating ef-
fect. Diabetes 1994;43:1015–9.
37. Torti M, Bertoni A, Canobbio I, et al. Rap1B and Rap2B
translocation to the cytoskeleton by von Willebrand factor
involves Fc gamma II receptor-mediated protein tyrosine
phosphorylation. J Biol Chem 1999:274:13690–7.
38. Sargeant P, Farndale RW, Sage SO. ADP and thapsigar-
gin-evoked Ca2+ entry and protein tyrosine phosphoryla-
tion are inhibited by the tyrosine kinase inhibitors genistein
and methyl-2,5-dihydroxycinnamate in fura-2-loaded hu-
man platelets. J Biol Chem 1993;268:18151–6.
39. Kansra SV, Reddy MA, Weng YI, et al. Activation of
mitogen activated protein kinase in human platelets by
genistein. Pharmacol Res 1999;39:21–31.
24. Jayatilake GS, Jayasuriya H, Lee E-S, et al. Kinase inhibi-
J Cardiovasc Pharmacol™, Vol. 40, No. 3, 2002